Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 28, 2021; 27(40): 6888-6907
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6888
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6888
Compound | Standard curve | R² | Range (ng/mL) |
CDCA | Y = 0.0235X - 0.0056 | 0.9981 | 2.5-1000 |
UDCA | Y = 0.0013X + 0.2156 | 0.9972 | 1.25-500 |
GCA | Y = 0.0164X + 1.1577 | 0.9956 | 1.25-500 |
GDCA | Y = 0.0025X + 0.833 | 0.9982 | 1.25-500 |
TCA | Y = 0.0198X - 0.0113 | 0.9953 | 1.25-500 |
TUDCA | Y = 0.0332X + 0.0023 | 0.9985 | 2.5-1000 |
TCDCA | Y = 0.0306X + 0.00422 | 0.9923 | 2.5-1000 |
GCDCA | Y = 0.0133X - 0.00324 | 0.9915 | 2.5-1000 |
GLCA | Y = 0.0018X + 0.00242 | 0.9931 | 2.5-1000 |
DCA | Y = 0.0076X + 0.00614 | 0.9956 | 2.5-1000 |
CA | Y = 0.0916X - 0.00465 | 0.9987 | 2.5-1000 |
- Citation: Wang MF, Zhao SS, Thapa DM, Song YL, Xiang Z. Metabolomics of Fuzi-Gancao in CCl4 induced acute liver injury and its regulatory effect on bile acid profile in rats. World J Gastroenterol 2021; 27(40): 6888-6907
- URL: https://www.wjgnet.com/1007-9327/full/v27/i40/6888.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i40.6888